| 
Results for caivt. Search took 0.22 seconds.
MedImmune's Investigational Intranasal Influenza Vaccine, CAIV-T (cold adapted influenza vaccine, trivalent) Led to Higher Antibody Responses in Young Children Compared to Injectable
in Straightfromthedoc, on October 17, 2006
A study recently announced by MedImmune, Inc. (Nasdaq: MEDI ) revealed higher influenza serum antibody responses in children receiving the company's next-generation, investigational intranasal influenza vaccine , CAIV-T (cold adapted influenza vaccine, trivalent), than in children ...